Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-17

Clinical Trial Update: A Pilot Study Using Rocuronium to Prevent Intermediate Syndrome After Organophosphorus Insecticide Poisoning [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 pilot trial evaluated whether rocuronium can prevent intermediate syndrome after organophosphate poisoning. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rocuronium (rocuronium bromide)

Snippet

Sponsor: University of Edinburgh | Conditions: Organophosphate Poisoning | Phase 2, Phase 3 | Status: COMPLETED